Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial liver support

N L Sussman1, J H Kelly

  • 1Baylor College of Medicine, Amphioxus Inc., Houston, Tex., USA. budsus@watanabe.com

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same author

Optical characterization of the on-target OMEGA focal spot at high energy using the full-beam in-tank diagnostic.

Applied optics·2020
Same author

Tripled yield in direct-drive laser fusion through statistical modelling.

Nature·2019
Same author

Power balancing the multibeam OMEGA laser.

Applied optics·2018
Same author

One-stage combined delayed bladder closure with Kelly radical soft-tissue mobilization in bladder exstrophy: preliminary results.

Journal of pediatric urology·2018
Same journal

A study of suicide risk and prognostic characteristics in patients with osteosarcoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

The expression and mechanism of action of MicroRNA-210 in preeclampsia.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Multiparametric echocardiography for predicting recovery in moderate to severe sepsis-associated acute respiratory distress syndrome: A retrospective study.

Clinical and investigative medicine. Medecine clinique et experimentale·2025
See all related articles

Fulminant hepatic failure (FHF) presents acute metabolic deficits, unlike chronic liver failure. Recovery from FHF is possible through liver regeneration, making metabolic support crucial.

Area of Science:

  • Hepatology
  • Metabolic Medicine
  • Regenerative Medicine

Background:

  • Adequate liver function is essential for vital metabolic processes including energy supply and acid-base balance.
  • Fulminant hepatic failure (FHF) is characterized by acute metabolic deficits, contrasting with chronic liver failure's portal hypertension.
  • The liver's capacity for in vivo regeneration offers a potential for recovery from acute injury like FHF.

Purpose of the Study:

  • To review the theoretical and practical aspects of metabolic liver support.
  • To use fulminant hepatic failure (FHF) as a model for understanding metabolic liver support.
  • To explore the potential for liver regeneration in overcoming acute liver failure.

Main Methods:

  • Literature review of metabolic liver support strategies.

Related Experiment Videos

  • Analysis of FHF pathophysiology and regenerative capacity.
  • Examination of clinical data related to liver recovery and support.

    • Main Results:

    • FHF is defined by acute metabolic derangements, distinct from chronic liver conditions.
    • Hepatocyte division in vivo enables liver regeneration as a recovery mechanism for FHF.
    • Metabolic liver support is critical when regeneration is insufficient to prevent patient demise.

    Conclusions:

    • Metabolic liver support is a key consideration in managing fulminant hepatic failure (FHF).
    • The regenerative potential of the liver is central to recovery from acute liver injury.
    • Understanding metabolic support mechanisms is vital for improving outcomes in FHF.